Studies have shown that a dose of 50 mg/Kg PD reduced neuronal synaptic damage in Alzheimer's disease by inhibiting the Fyn/GluN2B/CaMKIIα signaling pathway [43]. This evidence concerns the gene CAMK2A and early-onset autosomal dominant Alzheimer disease.